The Significance and Implications of Nanotechnology in COVID-19

The coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a worldwide health hazard that has been classified as a pandemic by the World Health Organization (WHO). The task of developing efficient prevention and treatment measures for this p...

Full description

Saved in:
Bibliographic Details
Published inResearch journal of pharmacy and technology Vol. 16; no. 5; pp. 2499 - 2506
Main Authors Rahman, Mst. Mahfuza, Md, Kouser, Kumar Roy, Uthpall, Mohammad Shohan, Shahriar, Tasnim, Jarin, Islam, Md. Jahirul, Shila, Mst. Shagorika, Chakraborty, Sangita, Ibne Wahed, Mir Imam
Format Journal Article
LanguageEnglish
Published Raipur A&V Publications 01.05.2023
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a worldwide health hazard that has been classified as a pandemic by the World Health Organization (WHO). The task of developing efficient prevention and treatment measures for this pandemic is unparalleled. Due to nano-material's unique physicochemical features and controlled nano-bio interactions, nanotechnology has demonstrated significant potential in its capacity to combat a number of healthcare conditions. The application of nanotechnology for COVID-19 has been discussed in depth in this systematic review, which is divided into three sections: prevention, diagnostics, and treatment. To begin, we focused on nanotechnology-based protective equipment and disinfectants that can give much-needed protection against SARS-CoV-2. Again, nanoparticles can be used as an antigen carrier or adjuvant, paving the path for the development of a number of vaccines with preventive benefits. The capacity of nano-materials to magnify signal is then highlighted, which has been employed in the development of nano-biosensors and nano-imaging techniques that can be used for early-stage detection in conjunction with other diagnostic instruments. Finally, we discuss COVID-19 therapeutic approaches based on nano-materials. Nano-metals and their oxides affect cellular processes by interfering with the production of reactive oxygen species (ROS), which then give antiviral action. Various nano-products (polyethylenimine, squalene) can significantly lower the synthesis of inflammatory modulators (Cytokine storm), hence preventing Covid-19 infection. The review's limitations and nanoparticle's future directions for COVID-19 have been described briefly. This review is quite comprehensive and useful in terms of providing suggestions for developing nanomaterial-based devices to combat against COVID-19.
AbstractList The coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a worldwide health hazard that has been classified as a pandemic by the World Health Organization (WHO). The task of developing efficient prevention and treatment measures for this pandemic is unparalleled. Due to nano-material's unique physicochemical features and controlled nano-bio interactions, nanotechnology has demonstrated significant potential in its capacity to combat a number of healthcare conditions. The application of nanotechnology for COVID-19 has been discussed in depth in this systematic review, which is divided into three sections: prevention, diagnostics, and treatment. To begin, we focused on nanotechnology-based protective equipment and disinfectants that can give much-needed protection against SARS-CoV-2. Again, nanoparticles can be used as an antigen carrier or adjuvant, paving the path for the development of a number of vaccines with preventive benefits. The capacity of nano-materials to magnify signal is then highlighted, which has been employed in the development of nano-biosensors and nano-imaging techniques that can be used for early-stage detection in conjunction with other diagnostic instruments. Finally, we discuss COVID-19 therapeutic approaches based on nano-materials. Nano-metals and their oxides affect cellular processes by interfering with the production of reactive oxygen species (ROS), which then give antiviral action. Various nano-products (polyethylenimine, squalene) can significantly lower the synthesis of inflammatory modulators (Cytokine storm), hence preventing Covid-19 infection. The review's limitations and nanoparticle's future directions for COVID-19 have been described briefly. This review is quite comprehensive and useful in terms of providing suggestions for developing nanomaterial-based devices to combat against COVID-19.
Author Islam, Md. Jahirul
Kumar Roy, Uthpall
Chakraborty, Sangita
Rahman, Mst. Mahfuza
Md, Kouser
Tasnim, Jarin
Mohammad Shohan, Shahriar
Shila, Mst. Shagorika
Ibne Wahed, Mir Imam
Author_xml – sequence: 1
  givenname: Mst. Mahfuza
  surname: Rahman
  fullname: Rahman, Mst. Mahfuza
  organization: Department of Pharmacy, Comilla University, Koatbari, Cumilla - 3506, Bangladesh
– sequence: 2
  givenname: Kouser
  surname: Md
  fullname: Md, Kouser
  organization: Department of Pharmacy, Comilla University, Koatbari, Cumilla - 3506, Bangladesh
– sequence: 3
  givenname: Uthpall
  surname: Kumar Roy
  fullname: Kumar Roy, Uthpall
  organization: Department of Pharmacy, Comilla University, Koatbari, Cumilla - 3506, Bangladesh
– sequence: 4
  givenname: Shahriar
  surname: Mohammad Shohan
  fullname: Mohammad Shohan, Shahriar
  organization: Department of Pharmacy, Comilla University, Koatbari, Cumilla - 3506, Bangladesh
– sequence: 5
  givenname: Jarin
  surname: Tasnim
  fullname: Tasnim, Jarin
  organization: Department of Pharmacy, Comilla University, Koatbari, Cumilla - 3506, Bangladesh
– sequence: 6
  givenname: Md. Jahirul
  surname: Islam
  fullname: Islam, Md. Jahirul
  organization: Department of Pharmacy, Comilla University, Koatbari, Cumilla - 3506, Bangladesh
– sequence: 7
  givenname: Mst. Shagorika
  surname: Shila
  fullname: Shila, Mst. Shagorika
  organization: Department of Pharmacy, Comilla University, Koatbari, Cumilla - 3506, Bangladesh
– sequence: 8
  givenname: Sangita
  surname: Chakraborty
  fullname: Chakraborty, Sangita
  organization: Department of Pharmacy, Comilla University, Koatbari, Cumilla - 3506, Bangladesh
– sequence: 9
  givenname: Mir Imam
  surname: Ibne Wahed
  fullname: Ibne Wahed, Mir Imam
  organization: Department of Pharmacy, University of Rajshahi, Rajshahi - 6205, Bangladesh
BookMark eNo9kEtrAjEUhUOxUGv9CYVA12PzmjxWpdiXIHVRW7oLyXijI5rYybjw33fU0rs59xwO98J3jXoxRUDolpJRyRSl98QoUXBJvkeMMD4iRFB6gfr_ce9_p_oKDXNek26kLpnQffQwXwH-qJexDnXlYgXYxQWebHebzrZ1ihmngN9dTC1Uq5g2aXnAdcTj2dfkqaDmBl0Gt8kw_NMB-nx5no_fiunsdTJ-nBYVFaItIFTey7DQCgj1glMQC_DMC6UNKKq0J4pob8Ar54yUwvMgtQQmiDEGJB-gu_PdXZN-9pBbu077JnYvLdOcCVUySrpWeW5VTcq5gWB3Tb11zcFSYk-47JGFPXKxR1z2hIv_AoMnXSs
Cites_doi 10.1016/j.tmaid.2020.101697
10.1007/s41204-021-00109-0
10.1186/s13287-020-01866-6
10.1016/j.nano.2019.03.004
10.1186/s13063-019-3846-x
10.1016/j.scitotenv.2020.142363
10.1007/s41204-021-00102-7
10.3390/nano10050852
10.1016/j.vaccine.2018.04.082
10.1016/j.nmni.2020.100679
10.1007/s13346-021-00911-y
10.1016/j.molimm.2017.09.001
10.1038/s41467-020-17317-y
10.1080/22221751.2020.1736644
10.3390/su12051841
10.1063/5.0043009
10.1038/s41565-020-0751-0
10.52711/2231-5691.2021.00042
10.1016/j.jtho.2020.02.010
10.1016/j.sintl.2020.100079
10.1021/acsnano.0c04421
10.1016/j.coelec.2020.08.011
10.3390/prosthesis3010005
10.2147/ijn.s241702
10.1016/j.sintl.2020.100046
10.2217/nnm-2018-0085
10.1038/nature03712
10.5958/0975-4377.2020.00037.3
10.4172/1745-7580-c3-021
10.1016/j.nantod.2021.101142
10.1186/s12929-019-0563-4
10.1021/jp801293a
10.1002/gch2.202000115
10.52711/2231-5691.2022.00008
10.1016/j.jbiosc.2020.01.008
10.1021/acsnano.0c05657
10.1186/s12951-020-00685-4
10.1128/jvi.78.12.6134-6142.2004
10.1016/j.sintl.2020.100038
10.5958/2231-5691.2020.00040.4
10.52711/2349-2996.2021.00117
10.1002/admi.201900622
10.3389/fchem.2020.00517
10.1021/acsnano.0c02823.s001
10.5958/2231-5713.2016.00019.2
10.1136/bmj.m3862
ContentType Journal Article
Copyright Copyright A&V Publications May 2023
Copyright_xml – notice: Copyright A&V Publications May 2023
DBID AAYXX
CITATION
04Q
04S
04W
3V.
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
CCPQU
FYUFA
GHDGH
K9.
M0S
PQEST
PQQKQ
PQUKI
PRINS
DOI 10.52711/0974-360X.2023.00411
DatabaseName CrossRef
India Database
India Database: Business
India Database: Science & Technology
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central
ProQuest One Community College
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
DatabaseTitle CrossRef
ProQuest Indian Journals
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Indian Journals: Business
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
Indian Journals: Science & Technology
ProQuest One Academic
ProQuest Central (Alumni)
DatabaseTitleList CrossRef
ProQuest Indian Journals
Database_xml – sequence: 1
  dbid: 7X7
  name: Health & Medical Complete (ProQuest Database)
  url: https://search.proquest.com/healthcomplete
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
EISSN 0974-360X
0974-306X
EndPage 2506
ExternalDocumentID 10_52711_0974_360X_2023_00411
GroupedDBID ---
04Q
04S
04W
3V.
7UP
7X7
8FI
8FJ
AAYXX
ABUWG
ADBBV
AFKRA
AHMBA
ALMA_UNASSIGNED_HOLDINGS
BAI
BAW
BENPR
BPHCQ
BVXVI
CCPQU
CITATION
FYUFA
HMCUK
IAO
LXO
MV.
NFBOU
NKUNM
NXXTH
NYMDV
OK1
PQQKQ
PROAC
UKHRP
~ZZ
7XB
8FK
K9.
PQEST
PQUKI
PRINS
ID FETCH-LOGICAL-c144t-efcbb6fd87e01b431e4deb2b4789e7178b0708b9eb7aa9664b3f686e240999e63
IEDL.DBID BENPR
ISSN 0974-3618
IngestDate Thu Oct 10 19:50:31 EDT 2024
Fri Aug 23 02:42:40 EDT 2024
IsPeerReviewed false
IsScholarly true
Issue 5
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c144t-efcbb6fd87e01b431e4deb2b4789e7178b0708b9eb7aa9664b3f686e240999e63
PQID 2832475210
PQPubID 1096441
PageCount 8
ParticipantIDs proquest_journals_2832475210
crossref_primary_10_52711_0974_360X_2023_00411
PublicationCentury 2000
PublicationDate 2023-05-01
PublicationDateYYYYMMDD 2023-05-01
PublicationDate_xml – month: 05
  year: 2023
  text: 2023-05-01
  day: 01
PublicationDecade 2020
PublicationPlace Raipur
PublicationPlace_xml – name: Raipur
PublicationTitle Research journal of pharmacy and technology
PublicationYear 2023
Publisher A&V Publications
Publisher_xml – name: A&V Publications
References ref13
ref12
ref15
ref14
ref11
ref10
ref17
ref16
ref19
ref18
ref51
ref50
ref46
ref45
ref48
ref47
ref42
ref41
ref44
ref43
ref49
ref8
ref7
ref9
ref4
ref3
ref6
ref5
ref40
ref35
ref34
ref37
ref36
ref31
ref30
ref33
ref32
ref0
ref2
ref1
ref39
ref38
ref24
ref23
ref26
ref25
ref20
ref22
ref21
ref28
ref27
ref29
References_xml – ident: ref30
  doi: 10.1016/j.tmaid.2020.101697
– ident: ref23
  doi: 10.1007/s41204-021-00109-0
– ident: ref46
  doi: 10.1186/s13287-020-01866-6
– ident: ref43
  doi: 10.1016/j.nano.2019.03.004
– ident: ref15
  doi: 10.1186/s13063-019-3846-x
– ident: ref25
  doi: 10.1016/j.scitotenv.2020.142363
– ident: ref28
  doi: 10.1007/s41204-021-00102-7
– ident: ref19
  doi: 10.3390/nano10050852
– ident: ref38
  doi: 10.1016/j.vaccine.2018.04.082
– ident: ref4
  doi: 10.1016/j.nmni.2020.100679
– ident: ref26
  doi: 10.1007/s13346-021-00911-y
– ident: ref35
  doi: 10.1016/j.molimm.2017.09.001
– ident: ref11
– ident: ref17
– ident: ref6
  doi: 10.1038/s41467-020-17317-y
– ident: ref45
  doi: 10.1080/22221751.2020.1736644
– ident: ref9
  doi: 10.3390/su12051841
– ident: ref33
  doi: 10.1063/5.0043009
– ident: ref29
  doi: 10.1038/s41565-020-0751-0
– ident: ref1
  doi: 10.52711/2231-5691.2021.00042
– ident: ref16
  doi: 10.1016/j.jtho.2020.02.010
– ident: ref18
  doi: 10.1016/j.sintl.2020.100079
– ident: ref24
  doi: 10.1021/acsnano.0c04421
– ident: ref41
  doi: 10.1016/j.coelec.2020.08.011
– ident: ref40
– ident: ref34
  doi: 10.3390/prosthesis3010005
– ident: ref47
– ident: ref49
  doi: 10.2147/ijn.s241702
– ident: ref13
  doi: 10.1016/j.sintl.2020.100046
– ident: ref50
  doi: 10.2217/nnm-2018-0085
– ident: ref31
  doi: 10.1038/nature03712
– ident: ref7
  doi: 10.5958/0975-4377.2020.00037.3
– ident: ref37
  doi: 10.4172/1745-7580-c3-021
– ident: ref22
  doi: 10.1016/j.nantod.2021.101142
– ident: ref48
  doi: 10.1186/s12929-019-0563-4
– ident: ref44
  doi: 10.1021/jp801293a
– ident: ref20
  doi: 10.1002/gch2.202000115
– ident: ref0
  doi: 10.52711/2231-5691.2022.00008
– ident: ref32
  doi: 10.1016/j.jbiosc.2020.01.008
– ident: ref39
  doi: 10.1021/acsnano.0c05657
– ident: ref51
  doi: 10.1186/s12951-020-00685-4
– ident: ref36
  doi: 10.1128/jvi.78.12.6134-6142.2004
– ident: ref12
  doi: 10.1016/j.sintl.2020.100038
– ident: ref21
– ident: ref3
  doi: 10.5958/2231-5691.2020.00040.4
– ident: ref5
  doi: 10.52711/2349-2996.2021.00117
– ident: ref27
  doi: 10.1002/admi.201900622
– ident: ref8
  doi: 10.3389/fchem.2020.00517
– ident: ref42
  doi: 10.1021/acsnano.0c02823.s001
– ident: ref10
  doi: 10.5958/2231-5713.2016.00019.2
– ident: ref2
  doi: 10.1136/bmj.m3862
– ident: ref14
SSID ssj0000685248
Score 2.2840471
Snippet The coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a worldwide health hazard that has been...
SourceID proquest
crossref
SourceType Aggregation Database
StartPage 2499
SubjectTerms Drug delivery systems
Nanomaterials
Nanotechnology
Pandemics
Personal protective equipment
Title The Significance and Implications of Nanotechnology in COVID-19
URI https://www.proquest.com/docview/2832475210
Volume 16
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1BT4MwFG7cdvFiNGqczqUHr90KlBZOi84tm4nTqDPcGgqt2QWmw__vK3TTXbwRSCB8H7zve49HH0I3aRqnoMsBoZppwsBgEDBHHLayzIAjN35q6x2PCz5bsockTFzBbePaKrcxsQ7UeZnZGvnQjtRhAsSGjtafxE6Nsl9X3QiNFur4kCnQNurcTRbPL7sqC-VR6NcjtCgYZxJwL2p-4wl94XlDt5MmAztFfGAXn_L2BWo_PteiMz1GR84t4tuG3hN0oItTNAJq8evqo7BdPpY0nBY5nv9pDcelwRA2y2pXN8erAo-f3uf3xIvP0HI6eRvPiJuDQDJIdyqiTaYUN3kkNPUUKL5mOSTEioko1pCORQre20jFWgmAnnOmAsMjrkGswf5pHpyjdlEW-gJhSHhzoCA04OxYrEycci_PBFyGaR3QvIsG25uX62a5CwlpQo2WtGhJi5a0aMkarS7qbSGS7unfyF-uLv8_fIUO7amaBsIealdf3_oaRL5SfdQSieg7Pn8A4emiDQ
link.rule.ids 315,783,787,12068,21400,27936,27937,31731,33756,43322,43817,74073,74630
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3BToNAEN1oPejFaNRYrboHr9tCWXbh1JhqQ7WtB1vDbcPCrukFqsX_dwZotRdvBBIIb2Dem2HYR8h9koQJ8LLHHMMN4yAwGIgjAVtpakGR236C_Y7pTEQL_hz7cdNwWzdjlZucWCXqrEixR95DSx0ugWycweqToWsUfl1tLDT2yQGuw4UOBjKW2x6LIwK_XxloOSCbmSfcoP6Jx-9L1-01O524ix7iXVx6yt2lp93sXFHO6IQcN1qRPtTBPSV7Jj8jAwgsfVt-5DjjgyGjSZ7R8Z_BcFpYCkmzKLddc7rM6fD1ffzI3PCcLEZP82HEGhcElkKxUzJjU62FzQJpHFcD3xueQTmsuQxCA8VYoOGtDXRotATgheDasyIQBqgaxJ8R3gVp5UVuLgmFcjeDAPgWdB0PtQ0T4WaphMtwYzwna5Pu5ubVql7sQkGRUKGlEC2FaClES1VotUlnA5Fqnv21-o3U1f-H78hhNJ9O1GQ8e7kmR3jaepSwQ1rl17e5Abov9W0V0x_8DaKx
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1NT4NAEJ1omxgvRqPGatU9eN0WyrLAqdF-pPWjNmpNbxsWdk0vUC3-f2dhW-3FG4EEwnvZeW-GWQbgJo6jGHXZo45iijI0GBTNEcejJNHoyHUnNvWOpwkfzdj93J_b_qeVbatcx8QyUKd5YmrkbTNShwW-2XGibVvEtD_sLj-pmSBlvrTacRq7UA8Y95wa1O8Gk-nLpuLi8NDvlOO0HDTR1ONuWG3p8TuB67btSWfeMhPFW-ZHVO62WG3H6lKAhodwYJ0jua2oPoIdlR1DF2kmr4uPzHT8GAJJnKVk_KdNnOSaYAjNi00NnSwy0nt-H_epG53AbDh4642onYlAE0x9Cqp0IiXXaRgox5Wo_oqlmBxLFoSRwtQslLiGQxkpGSANnDPpaR5yhcKNVlBx7xRqWZ6pMyCY_KZIh6_R5bFI6ijmbpoE-BimlOekDWitX14sq19fCEwZSrSEQUsYtIRBS5RoNaC5hkjYlbASv7yd_3_5GvaQUPE4njxcwL65a9VX2IRa8fWtLlH7C3llSf0Bk_KoTg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Significance+and+Implications+of+Nanotechnology+in+COVID-19&rft.jtitle=Research+journal+of+pharmacy+and+technology&rft.au=Rahman%2C+Mahfuza&rft.au=Kouser%2C+Md&rft.au=Roy%2C+Uthpall+Kumar&rft.au=Shohan%2C+Shahriar+Mohammad&rft.date=2023-05-01&rft.pub=A%26V+Publications&rft.issn=0974-3618&rft.eissn=0974-306X&rft.volume=16&rft.issue=5&rft.spage=2499&rft.epage=2506&rft_id=info:doi/10.52711%2F0974-360X.2023.00411&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0974-3618&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0974-3618&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0974-3618&client=summon